Breathe Well Live Well
|
New Drug May Decrease Asthma Attacks By 87%
Medical News Today A novel, lab-made molecule was able to stick to certain inflammatory proteins and decrease and minimize acute breathing issues among people with moderate-to-severe asthma, according to new research by the University of Pittsburgh School of Medicine. |
View full post on asthma – Google News
 CBS News |
Experimental asthma drug helps untreatable patients in study
CBS News Asthma suffers who aren't helped by existing medications may have reason to breathe a sigh of relief. An experimental drug called dupilumab was shown to reduce asthma attacks and helped boost lung function for people with moderate to severe asthma … New drug could reduce asthma attacks by 87 percent Experimental drug touted as potential game changer for asthma sufferers UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer |
View full post on asthma – Google News
|
Phase III Success for Boehringer Ingelheim Asthma Drug
Genetic Engineering News Boehringer-Ingelheim said today its once-daily asthma drug tiotropium, delivered via Respimat® Soft Mist™ Inhaler, produced favorable Phase III results by increasing the time to first severe exacerbation, and time to first episode of asthma worsening … Boehringer Ingelheim's tiotropium shows promising results in patients with … Phase III results: tiotropium* Respimat® effective in symptomatic asthma … Boehringer Ingelheim reports positive data from symptomatic asthma trials |
View full post on asthma – Google News
 Science Recorder |
New drug could reduce asthma attacks by 87 percent
Fox News An experimental drug being developed by Regeneron Pharmaceuticals Inc. and Sanofi SA showed promising results during a small, mid-stage clinical trial in treating a subset of patients with moderate to severe asthma, but some physicians cautioned that … UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer New Asthma Drug Generates Excitement For Patients — And Its Maker Experimental drug touted as potential game changer for asthma sufferers |
View full post on asthma – Google News
 Investorplace.com |
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
Reuters May 21 (Reuters) – A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease … New Asthma Drug Generates Excitement For Patients — And Its Maker Antibody Gets High Marks for Asthma Control – MedPage Today Monoclonal Antibody Dupilumab Safe And Effective In Asthma Phase IIa Trial |
View full post on asthma – Google News
|
New Asthma Drug Generates Excitement For Patients — And Its Maker
Forbes An experimental asthma drug could give new hope to patients for whom existing medicines are not enough and give yet another boost to Regeneron Pharmaceuticals, the company developing it, which has seen its shares rise 376% in the past two years, … Regeneron, Sanofi asthma drug seen as potential game changer Monoclonal antibody appears effective and safe in asthma Phase IIa trial Sanofi, Regeneron Report Publication Of Phase 2a Results Of Dupilumab In … |
View full post on asthma – Google News
|
Regeneron, Sanofi asthma drug seen as potential game changer
Reuters (Reuters) – A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers … Monoclonal antibody appears effective and safe in asthma Phase IIa trial Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of … |
View full post on asthma – Google News
|
After Billions Are Made, Risks from Asthma Drug Emerge
CounterPunch World sales of Merck's blockbuster asthma drug, Singulair, were about $5 billion a year until last year when its patent expired in the United States. But the drug also has a darkening cloud over it. The Australian medicine watchdog has received 58 … |
View full post on asthma – Google News
|
Plan stopped covering asthma drug
Bangor Daily News I've been taking a new drug for my asthma and it's working beautifully. When I went to get it filled last time, the drug store told me it wasn't covered any more. Can a health plan stop covering a medicine in the middle of the year? What am I supposed … |
View full post on asthma – Google News
|
Trial asthma drug targets lung inflammation – Medical Xpress
Medical Xpress Speaking in the lead up to World Asthma Day (7 May), respiratory health expert Associate Professor Sandra Hodge (University of Adelaide School of Medicine and Royal Adelaide Hospital) says the trial treatment is aimed at helping asthma sufferers who … |
View full post on asthma – Google News